Guanggang Ma

Title: Innovations and Contributions of Guanggang Ma

Introduction

Guanggang Ma is a notable inventor based in Shanghai, China, recognized for his significant contributions to the field of biotechnology. He holds three patents that showcase his innovative approach to developing vaccines and immunogenic compositions.

Latest Patents

One of his latest patents is a recombinant virus capable of stably expressing target proteins. This invention provides a method to generate a recombinant virus that can stably express target proteins, which is useful for producing an immunogenic composition or vaccine. Another important patent is the recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C. This invention offers compositions or vaccines that contain a recombinant EHV-1 that elicits an immune response in animals against equine herpesvirus. It includes methods of vaccination against equine herpesvirus and kits for use with such methods and compositions.

Career Highlights

Throughout his career, Guanggang Ma has worked with prominent companies in the veterinary and pharmaceutical sectors, including Merial Limited and Boehringer Ingelheim Vetmedica (China) Co., Ltd. His work has significantly impacted the development of veterinary vaccines and treatments.

Collaborations

Guanggang Ma has collaborated with esteemed professionals in his field, including Jean Christophe Audonnet and Jules Maarten Minke. These collaborations have further enhanced his research and contributions to biotechnology.

Conclusion

Guanggang Ma's innovative work in developing recombinant viruses and vaccines demonstrates his commitment to advancing biotechnology. His patents and collaborations reflect his significant impact on the field, particularly in veterinary medicine.